Stent thrombosis redux--the FDA perspective

N Engl J Med. 2007 Mar 8;356(10):984-7. doi: 10.1056/NEJMp068304. Epub 2007 Feb 12.

Authors

Andrew Farb¹, Ashley B Boam

Affiliation

¹ Interventional Cardiology Devices Branch, of the Office of Device Evaluation, Center for Devices and Radiological Health, FDA, Rockville, USA.

PMID: 17296827
DOI: 10.1056/NEJMp068304

No abstract available

MeSH terms

Advisory Committees
Angioplasty, Balloon, Coronary
Coronary Disease / therapy*
Coronary Thrombosis / etiology*
Device Approval*
Drug Delivery Systems
Humans
Myocardial Infarction / etiology
Prosthesis Design
Prosthesis Failure
Risk
Stents / adverse effects*
United States
United States Food and Drug Administration*